Dr. Maral K. Skelsey is a dermatologist in Chevy Chase,Maryland. She graduated from Washington University School of Medicine in 1991 and has been in practice for 31 years.
Female
1699750315
Description | # of Times Performed | # of Patients | Average Charge ($) |
---|---|---|---|
Drainage of abscess | 22.0 | 20.0 | 165.0 |
Tangential biopsy of single skin lesion | 587.0 | 458.0 | 166.17376491 |
Tangential biopsy of additional skin lesion | 143.0 | 116.0 | 74.055944056 |
Punch biopsy of single skin lesion | 43.0 | 41.0 | 211.62790698 |
Removal of malignant growth (1.1 to 2.0 centimeters) of the trunk, arms, or legs | 40.0 | 35.0 | 355.0 |
Injection of up to 7 skin growths | 80.0 | 53.0 | 95.0 |
Repair of wound (2.6 to 7.5 centimeters) of trunk | 39.0 | 38.0 | 600.0 |
Repair of wound (2.6 to 7.5 centimeters) of scalp, arms, and/or legs | 75.0 | 67.0 | 600.0 |
Repair of wound of scalp, arms, and/or legs | 31.0 | 26.0 | 175.0 |
Repair of wound (2.6 to 7.5 centimeters) of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, and/or feet | 73.0 | 66.0 | 600.0 |
Tissue transfer repair of wound (10 sq centimeters or less) of the forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, and/or feet | 14.0 | 13.0 | 1000.0 |
Tissue transfer repair of wound (10 sq centimeters or less) of eyelids, nose, ears, and/or lips | 21.0 | 21.0 | 1000.0 |
Destruction of skin growth | 804.0 | 564.0 | 125.0 |
Destruction of 2-14 skin growths | 1648.0 | 383.0 | 24.908980583 |
Destruction of 15 or more skin growths | 38.0 | 33.0 | 331.0 |
Destruction of up to 14 skin growths | 391.0 | 300.0 | 175.0 |
Destruction of 15 or more skin growths | 27.0 | 24.0 | 200.0 |
Destruction of malignant growth (1.1 to 2.0 centimeters) of trunk, arms, or legs | 16.0 | 13.0 | 153.125 |
Removal and microscopic examination of growth of the head, neck, hands, feet, or genitals (first stage, up to 5 tissue blocks) | 178.0 | 151.0 | 1113.0 |
Removal and microscopic examination of growth of the head, neck, hands, feet, or genitals | 100.0 | 68.0 | 500.0 |
Removal and microscopic examination of growth of the trunk, arms, or legs (first stage, up to 5 tissue blocks) | 80.0 | 72.0 | 1000.0 |
Removal and microscopic examination of growth of the trunk, arms, or legs | 36.0 | 30.0 | 500.0 |
Strapping, Unna boot | 52.0 | 39.0 | 75.0 |
Pathology examination of tissue using a microscope, moderately low complexity | 23.0 | 21.0 | 60.0 |
Pathology examination of tissue using a microscope, intermediate complexity | 831.0 | 478.0 | 59.855595668 |
Special stained specimen slides to identify organisms including interpretation and report | 48.0 | 29.0 | 60.0 |
Special stained specimen slides to examine tissue including interpretation and report | 47.0 | 26.0 | 60.0 |
Pathology examination of tissue during surgery | 28.0 | 28.0 | 175.0 |
Special stained specimen slides to examine tissue | 92.0 | 55.0 | 58.695652174 |
Tissue or cell analysis by immunologic technique | 69.0 | 64.0 | 60.0 |
Application of light and light-sensitive drugs to aid destruction of premalignant skin growths, per day | 80.0 | 54.0 | 250.0 |
Application of light and light-sensitive drugs following removal of premalignant thickened skin growth, per day | 35.0 | 26.0 | 300.0 |
New patient office or other outpatient visit, typically 20 minutes | 50.0 | 50.0 | 125.0 |
New patient office or other outpatient visit, typically 30 minutes | 148.0 | 148.0 | 200.0 |
New patient office or other outpatient visit, typically 45 minutes | 66.0 | 66.0 | 275.0 |
Established patient office or other outpatient visit, typically 10 minutes | 1033.0 | 533.0 | 65.1839303 |
Established patient office or other outpatient visit, typically 15 minutes | 838.0 | 591.0 | 125.0 |
Established patient office or other outpatient, visit typically 25 minutes | 910.0 | 719.0 | 200.0 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 96.0 | 52.0 | 5.0 |
Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 121.0 | 79.0 | 450.0 |
Cookies on this website are used to improve your experience and display advertising. You agree to the use of cookies by continuing to use this website. Our Privacy Policy contains more information about how we use cookies.